Figure 2.
Spectral domain optical coherence tomography (A), fluorescein angiogram (B), and spectral domain optical coherence tomography thickness map (C) of the left eye after treatment with difluprednate.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.